First Time Loading...
C

Cabio Biotech Wuhan Co Ltd
SSE:688089

Watchlist Manager
Cabio Biotech Wuhan Co Ltd
SSE:688089
Watchlist
Price: 15.25 CNY -2.12% Market Closed
Updated: Jun 3, 2024
Cabio Biotech Wuhan Co Ltd
/
Income Statement
/
Income from Continuing Operations

Cabio Biotech Wuhan Co Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cabio Biotech Wuhan Co Ltd
Income from Continuing Operations Peer Comparison

Comparables:
603659
600309
603260
C
300919
002466

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
C
Cabio Biotech Wuhan Co Ltd
SSE:688089
Income from Continuing Operations
¥61.6m
CAGR 3-Years
-20%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Shanghai Putailai New Energy Technology Co Ltd
SSE:603659
Income from Continuing Operations
¥1.9B
CAGR 3-Years
24%
CAGR 5-Years
25%
CAGR 10-Years
N/A
Wanhua Chemical Group Co Ltd
SSE:600309
Income from Continuing Operations
¥18.5B
CAGR 3-Years
6%
CAGR 5-Years
6%
CAGR 10-Years
17%
Hoshine Silicon Industry Co Ltd
SSE:603260
Income from Continuing Operations
¥2.1B
CAGR 3-Years
1%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
C
CNGR Advanced Material Co Ltd
SZSE:300919
Income from Continuing Operations
¥2.1B
CAGR 3-Years
71%
CAGR 5-Years
102%
CAGR 10-Years
N/A
Tianqi Lithium Corp
SZSE:002466
Income from Continuing Operations
¥16.4B
CAGR 3-Years
N/A
CAGR 5-Years
48%
CAGR 10-Years
N/A

See Also

What is Cabio Biotech Wuhan Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
61.6m CNY

Based on the financial report for Dec 31, 2022, Cabio Biotech Wuhan Co Ltd's Income from Continuing Operations amounts to 61.6m CNY.

What is Cabio Biotech Wuhan Co Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
-1%

Over the last year, the Income from Continuing Operations growth was -53%. The average annual Income from Continuing Operations growth rates for Cabio Biotech Wuhan Co Ltd have been -20% over the past three years , -1% over the past five years .

ALPHA SPREAD
Join more than 143,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.